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The primary amino acid sequence within a stretch of 25 residues (positions 91-116) of the middle portion 
of the 3-'orf protein (p273'-or0 of the human immunodeficiency virus (HIV) shares structural homology 
with a highly charged region within the intracytoplasmic phosphorylation domain of human interleukin-2 
receptor (IL-2R) and the ATP-binding site of the catalytic subunit of cAMP-dependent protein kinase 
(cAMP-PK) and other members of the protein kinase family. Comparison of the predicted secondary struc- 
ture within this region of p273'-orf with the phosphorylation domain of human IL-2R and the ATP-binding 
region of the phospho-kinase family of protein suggests that the 3'-orf protein could serve homologous func- 
tion(s). 
3'-orf protein; IL-2 receptor; Phosphorylation domain; ATP-binding site; Protein kinase family; 
Human immunodeficiency virus 
1. INTRODUCTION 
The genome of HIV, the infectious agent linked 
with AIDS and ARCs [1-3], encodes viral gag, pol 
and env genes typical of other retroviruses [4-7]. 
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However, unlike the typical retrovirus, other genes 
are present, including the tat, art, sor, and 3' -or f  
[4-7]. The 3' -or f  gene (648 bp) begins in a dif- 
ferent reading frame at the end of the gp41 
envelope sequence, and extends into the 3' -LTR 
where it terminates in the U3 region [4-7]. A 
premature termination codon (TAG) at position 
124 truncates the gene product (124 amino acids) in 
HIV isolates HX-B2 and BH10 [4,8], whereas most 
other isolates are predicted to express a protein of 
206 amino acids [9,10]. This protein, p273 ,-o~f [9], 
has been localized to the cytoplasmic fraction of 
Molt-4 infected [11] and H9-infected ([11], and 
Samuel, K. Showalter S. and Zweig, M., unpub- 
lished) T-cells. 
As a first step towards delineating a possible 
function for p273'-°~f during HIV infection, a 
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search was conducted for structural homology 
with other cellular or viral oncogene proteins 
previously localized to the cytoplasm. This report 
describes the finding of sequence homology be- 
tween p273'-°rf, the protein kinase C catalyzed 
phosphorylation domain within the short in- 
tracytoplasmic tail of human IL-2R, and the 
nucleotide-binding site of the protein kinase family 
of proteins. 
2. EXPERIMENTAL AND RESULTS 
An initial visual search of the deduced amino 
acid sequences of T-cell receptors IL-2R and T4 
(CD4) antigen revealed a stretch of highly charged, 
mainly basic residues of consensus QRRQ(Xaa)6I, 
at positions 241-251 of the intracytoplasmic tail of 
human IL-2R [12,13], showing striking sequence 
homology ( -41%) with a highly charged region 
(positions 104-114) within the p273'-°rf protein of 
HIV isolates, located just prior to the premature 
termination codon found in the 3 ' -or f  sequence 
of some infectious HIV isolates [8]. As summar- 
ized in fig.l, this sequence is highly conserved, 
with few amino acid changes, among all of the 
HIV isolates, and has also been identified among 
a limited but diverse group of proteins, including 
N-myc [14] and cytochrome P-450 of Pseudo- 
monas putida [15]. The significance of this 
homology is not yet understood. However, it is 
known that stimulation of resting T-cells with 
mitogens and antigens triggers the activation of 
protein kinase C catalyzed phosphorylation of 
serine (S) residue 247 and threonine (T)-250 at the 
Protein 
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Fig.1. Alignment of amino acid residues around the QRRQ(Xaa)6I consensus of human IL-2R and HIV p273'-°~f. 
Identifying symbols: (+) serine-247 and threonine-250 of human IL-2R; (o) highly conserved serine-103 and 
threonine-117 of p273'-°rf; (zX) less conserved tyrosines-ll 5 and -120 of p273'-°rf; ( .)  termination codons. References 
cited for HIV isolates: LAV strains BRU, MAL, and ELI [5]; HXB2, HXB3, C15, HAT3, BHI0, BHS, PV22, and 
SF2 [8]; and CDC451 isolate [38]. The one letter amino acid code is used. 
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intracytoplasmic domain of human IL-2R [16,17]. 
Located within the corresponding p273'-°rf se- 
quence are a threonine (T) at position 117 and 
serine (S) at 103, which are highly conserved 
among all HIV isolates (fig.l), and are potential 
targets of protein kinase C catalyzed phosphor- 
ylation. 
We then looked for structural relationship be- 
tween p27 ~ ' -o~f and conserved sequences at the ac- 
tive site of the protein kinases and proteins that are 
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Fig.2. Alignment of amino acid sequences at the ATP-binding site of the protein kinase (PK) family. Closed boxes 
identify conserved consensus or canonical residues of known and putative members of the PK family. Broken-line boxes 
enclose residues in p2732'-°rf and subfamilies of nucleotide-binding proteins having a highly conserved DILD or ILD 
sequence. Numbers in parentheses are amino acid coordinates at end of sequences identified. Sequences were aligned 
by eye. 
83 
Volume 218, number 1 FEBS LETTERS June 1987 
themselves targets for protein kinase catalyzed 
phosphorylation. During this search, a glycine (G)- 
rich cluster of amino acids, located only four 
residues N-terminal to the QRRQ consensus in 
p273'°rf, was identified (residues 93-112), which 
showed striking sequence homology with the 
glycine-rich canonical GX~aGXaaXaaG sequence of 
the catalytic subunit of bovine cAMP-PK [18], the 
prototype of a family of homologous protein 
kinases [19]. As shown in fig.2, only a single gap 
(-) was introduced between the first and second G- 
residues of p273'-°ff to maximize the homology. 
This apparent structural homology between the 
HIV p27 a'-°'f protein and the nucleotide-binding 
region of the protein kinase family [18,19] raises 
interesting questions about possible structural and 
functional evolution of this viral protein. A con- 
served lysine (K) residue proposed to be critical in 
binding ATP or other nucleotides by the cAMP- 
PK [20], oncogene ncoded tyrosine and serine/ 
threonine protein kinases [19], and growth factor 
receptor kinases [21,22], is positioned 15-28 
residues C-terminal to the glycine-rich cluster 
(fig.2). However, a corresponding lysine residue is 
not similarly located in the HIV p273'-°rf protein, 
which was replaced by either a glutamic (E) or 
aspartic (D) acid among different viral isolates (see 
also fig. 1). In some HIV isolates, a lysine is located 
two amino acids preceding the E or D residues. 
Moreover, the ,,primary amino acid sequence 
around the VA~K consensus, which is located 
15-28 residues from the glycine-rich cluster, ap- 
pears to be quite variable among the subfamilies of 
protein kinases. Thus within this region of a con- 
sensus nucleotide-binding sequence, p273' -off more 
closely resembles the viral oncogene p21 raS, a 
guanine nucleotide-binding protein [23]~ in that 
they both lack the VAVK consensus (fig.2) and 
instead have retained the ILD or DILD sequence 
in the same relative position (broken-line box). 
Similarly, the dinucleotide-binding proteins, 
such as lactate dehydrogenase (LDH) and glu- 
tathione reductase (GR) (fig.2), also lack the cor- 
responding lysine residue at the VAVK consensus. 
It is of interest o also note that the regulatory 
subunit of bovine cAMP-PK, which binds cAMP 
but lacks kinase activity [24], resembles p273' -o~f in 
having GGX~aXaaG as the glycine-rich sequence 
(GGSFG), while the third glycine residue of 
phos.b-K is replaced by a serine (fig.2). 
A comparison of the predicted secondary struc- 
ture of p273'-°~f surrounding the receptor-like and 
nucleotide-binding consensus equences was con- 
ducted, using the algorithm of Garnier et al. [25]. 
The results are summarized in fig.3. The program 
predicts that the QRRQ consensus equence of 
human IL-2R and p273'-°'f of HIV isolates with 
unmodified QRRQ sequence, favor the beginning 
of turn (T) regions (fig.3A,B) while the GXaaGX- 
aaXaaG glycine-rich consensus of p21 ras (fig.3D) 
and GGXaaXaaG of p273'-°rf (fig.3B) are found at 
or close to the beginning of random coil (C) 
regions. Amino acid changes at the QRRQ site in 
other HIV isolates (fig.3C) resulted in a reversal of 
the configuration at that site. The ATP-binding 
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Fig.3. Predicted secondary structure analysis of QRRQ 
consensus and GXaaGXaaXaaG sequence in p273'-°~f 
compared to human IL-2R and kinase related proteins. 
Symbols in last lines of A-E denote the following 
secondary structural features: A, antiparallel B-sheet; C, 
random coil; H, or-helix; P, parallelfl-sheet; T, turn. The 
regions indicated by 'star-dash' lines above the sequence 
mark the actual GTP (D) and ATP (E) binding sites of 
p21 ras and cAMP-PK proteins, respectively. 
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region of the cAMP-PK is located between two or- 
helical (H) regions (fig.3D). The BomB unit struc- 
ture originally proposed for the configuration at 
the dinucleotide-binding pocket of dehydrogenase 
enzymes was adapted as a model structure for the 
analogous site of the protein kinases [26-28]. The 
QRRQ consensus of the intracytoplasmic domain 
of human IL-2R occurs at a turn (T) region, since 
such turn configuration is located at the junction 
between transmembrane (TM) and peripheral 
areas of membrane receptor proteins [25,29]. 
Thus, the results of computer modeling summa- 
rized in fig.3 reveal different configurations 
around the QRRQ consensus of p273'-°~f proteins 
due to amino acid changes (fig.3B,C) within the 
sequence in some HIV isolates. These structural 
features therefore suggest, but do not prove, that 
the p27 TM protein of HIV possesses both a 
receptor-like phosphorylation domain similar to 
human IL-2R and a nucleotide-binding domain 
resembling that of the protein kinase family. 
3. DISCUSSION 
At present, no known function has as yet been 
ascribed to the 3'-orf gene of HIV. The protein 
product of this gene or its truncated analogue may 
act to repress viral replication [30,31] during HIV 
infection of T-cells in culture. The protein is 
relatively immunogenic n the native host [9,12], 
has been localized to the soluble cytoplasmic frac- 
tion of infected T-cells ([11], and Samuel, K., 
Showalter S. and Zweig, M., unpublished), and 
was reported to be modified at its N-terminus by 
myristylation [9], thus suggesting a possible mem- 
brane association [32]. The catalytic subunit of 
cAMP-PK and the protein phosphatase calcineurin 
are also soluble cellular proteins modified by 
myristylation [33,34]. It is of great interest hat 
p273'-°~f more closely resembles the p21 ras on- 
cogene protein at its guanine nucleotide-binding 
site, with conservation of the DILD sequence and 
loss of the conserved lysine (K) residue in p21 ras 
and 3'-orf protein of the various HIV isolates. 
Since p21ras is known to bind GTP, 
autophosphorylates, and possesses an intrinsic 
GTPase activity [23,35], homologous biochemical 
properties of p273'-°~ should be sought, not- 
withstanding differences in their predicted secon- 
dary structure around the DILD motif. The 
possibility of interaction between p273'-°rf with 
viral or cellular targets uch as DNA, RNA, and 
proteins, and phosphorylation by cellular PK-C, 
should also be examined. 
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ADDENDUM 
After submission of this manuscript for publica- 
tion, the recently identified consensus equence 
elements at the GTP-binding domain of guanine 
nucleotide-binding proteins [39] were also found to 
be conserved in the 3'-orf protein of HIV. The 
consensus GTP-binding domain in p27 TM is 
(6)GXXXXXXGK(14) - -- (38)DXXG(41 )--- (167)- 
NKXE(170). Numbers in brackets represent amino 
acid positions [5]. 
REFERENCES 
[1] Barre-Sinoussi, F., Chermann, J.C., Rey, F., 
Nugeyre, M.T., Chamaret, S., Gruest, J., 
Danguet, C., Axler-Blin, C., Vezinet-Brun, F., 
Rouzioux, C., Rozenbaum, W. and Montagnier, L.
(1983) Science 220, 868-871. 
[2] Popovic, M., Sarngadharan, M.G., Read, E. and 
Gallo, R.C. (1984) Science 224, 497-500. 
[3] Levy, J.A., Hoffman, A.D., Kramer, S.M., 
Landis, J.A., Shimabukuro, J.M. and Oshiro, L.S. 
(1984) Science 225, 840-842. 
[4] Ratner, L., Haseltine, W., Patarca, R., Livak, 
K.J., Starcich, B., Josephs, S.F., Doran, E.R., 
Rafalski, J.A., Whitehom, E.A., Baumeister, K., 
Ivanoff, L., Petteway, S.R. jr, Pearson, M.L., 
Lautenberger, J.A., Papas, T.S., Ghrayeb, J., 
Chang, N.T., Gallo, R.C. and Wong-Staal, F.
(1985) Nature 313, 277-284. 
[5] Wain-Hobson, W., Sonigo, P., Danos, O., Cole, 
S. and Alizon, M. (1985) Cell 40, 9-17. 
85 
Volume 218, number 1 FEBS LETTERS June 1987 
[6] Sanchez-Pescador, R. Power, M.D., Barr, P.J., 
Steimer, K.S., Stempien, M.M., Brown-Shimer, 
S.L., Gee, W.W., Renard, A., Randolph, A., 
Levy, J.A., Dina, D. and Luciw, P.A. (1985) 
Science 227, 484-492. 
[7] Muesing, M.A., Smith, D.H., Cabradilla, C.D., 
Benton, C.V., Lasky, L.A. and Capon, D.J. (1985) 
Nature 313, 450-458. 
[8] Ratner, L., Starcich, B., Josephs, S.F., Hahn, 
B.H., Reddy, E.P., Livak, K.J., Petteway, S.R. jr, 
Pearson, M.L., Haseltine, W.A., Arya, S.K. and 
Wong-Staal, F. (1985) Nucleic Acids Res. 13, 
8219-8229. 
[9] Allan, J.S., Coligan, J.E., Lee, T.-H., McLane, 
M.F., Kanki, P.J., Groopman, J.E. and Essex, M. 
(1985) Science 230, 810-813. 
[10] Franchini, G., Robert-Guroff, M., Wong-Staal, 
F., Ghrayeb, J., Kato, I., Chang, T.W. and Chang, 
N.T. (1986) Proc. Natl. Acad. Sci. USA 83, 
5282-5285. 
Ill] Franchini, G., Robert-Guroff, M., Ghrayeb, J., 
Chang, N.T. and Wong-Staal, F. (1986) Virology 
155, 593-599. 
[12] Leonard, W.J., Depper, J.M., Crabtree, G.R., 
Rudikoff, S., Pumphrey, J., Robb, R.J., Kronke, 
M., Svetlik, P.B., Peffer, N.J., Waldmann, T.A. 
and Greene, W.C. (1984) Nature 311, 626-631. 
[13] Nikaido, T., Shimizu, A., Ishida, N., Sabe, H., 
Teshigawara, K., Meada, M., Uchiyama, T., 
Yodoi, J. and Honjo, T. (1984) Nature 311, 
631-635. 
[14] Kohl, N.E., Legouy, E., DePinho, R.A., Nisen, 
P.D., Smith, R.K., Gee, C.E. and Alta, F.W. 
(1986) Nature 319, 73-77. 
[15] Haniu, M., Armes, L.G., Yasunobu, K.T., 
Shastry, B.A. and Gunsalus, I.C. (1982) J. Biol. 
Chem. 257, 12664-12671. 
[16] Shackelford, D.A. and Trowbridge, I.S. (1984) J. 
Biol. Chem. 259, 11706-11712. 
[17] Gallis, B., Lewis, A., Wignall, J., Alpert, A., 
Moshizuki, D.Y., Cosman, D., Hopp, T. and 
Urdal, D. (1986) J. Biol. Chem. 261, 5075-5080. 
[18] Barker, W.C. and Dayhoff, M.O. (1982) Proc. 
Natl. Acad. Sci. USA 79, 2836-2839. 
[19] Hunter, T. and Copper, J.A. (1986) The Enzymes 
17, 191-247. 
[20] Zoller, M.J. and Taylor, S.S. (1979) J. Biol. Chem. 
254, 8363-8367. 
[21] Russo, M.W., Lukas, T.H., Cohen, S. and Staros, 
J.V. (1985) J. Biol. Chem. 260, 5205-5208. 
[22] Chou, C.K., Dull, T.J., Russell, D.S., Gherzi, R., 
Lehwohl, D., Ulrich, A. and Rosen, O.M. (1987) J. 
Biol. Chem. 262, 1842-1847. 
[23] Hattori, S., Ulsh, L.S., Halliday, K. and Shih, 
T.Y. (1985) Mol. Ceil. Biol. 5, 1449-1455. 
[24] Titani, K., Sasagawa, T., Ericsson, L.H., Kumar, 
S., Smith, S.B., Krebs, E.G. and Walsh, K.A. 
(1984) Biochemistry 23, 4193-4199. 
[25] Garnier, J., Osguthorpe, D.J. and Robson, B. 
(1978) J. Mol. Biol. 120, 97-120. 
[26] Rossmann, M.G., Liljas, A., Branden, C.-I. and 
Banaszak, L.J. (1975) The Enzymes 11, 61-102. 
[27] Wierenga, R.K. and Hol, W.G.J. (1983) Nature 
302, 842-844. 
[28] Sternberg, M.J.E. and Taylor, W.R. (1984) FEBS 
Lett. 175, 387-392. 
[29] Chou, P.Y. and Fasman, G.D. (1974) Biochemistry 
13, 222-245. 
[30] Fisher, A.G., Ratner, L., Mitsuya, H., Marselle, 
L.M., Harper, M.E., Broder, S., Gallo, R.C. and 
Wong-Staal, F. (1986) Science 233, 655-659. 
[31] Terwilliger, E., Sodroski, J.G., Rosen, C.A. and 
Haseltine, W.A. (1986) J. Virol. 60, 754-760. 
[32] Garber, E.A., Cross, F.R. and Hanafusa, H. 
(1985) Mol. Cell. Biol. 5, 2781-2788. 
[33] Cart, S.A., Blemann, K., Shoji, S., Parmelee, 
D.C. and Titani, K. (1982) Proc. Natl. Acad. Sci. 
USA 79, 6128-6131. 
[34] Aitken, A., Cohen, P., Santikarn, S., Williams, 
D.H., Calder, A.G., Smith, A. and Klee, C.B. 
(1982) FEBS Lett. 150, 314-318. 
[35] Sweet, R.W., Yokoyama, S., Kamata, T., 
Feramisco, J.R., Rosenberg, M. and Gross, M. 
(1984) Nature 311, 273-275. 
[36] Parker, P.J., Coussens, L., Totty, N., Rhee, L., 
Young, S., Chen, E., Stabel, S., Waterfield, M.D. 
and UUrich, A. (1986) Science 233, 853-859. 
[37] Yuasa, Y., Srivastava, S.K., Dunn, C.Y., Rhim, 
J.S., Reddy, E.P. and Aaronson, S.A. (1983) 
Nature 303, 775-779. 
[38] Desai, Kalyanaraman, V.S., Casey, J.M., 
Srinivasan, A., Andersen, P.R. and Devare, S.G. 
(1986) Proc. Natl. Acad. Sci. USA 83, 8380-8384. 
[39] Dever, T.E., Glynias, M.J. and Merrick, W.C. 
(1987) Proc. Natl. Acad. Sci. USA 84, 1314-1818. 
86 
